无抽搐电休克联合SSRI治疗对重度抑郁症患者认知功能的影响

doi:10.3760/cma.j.issn.1007-1245.2024.11.022

国际医药卫生导报 ›› 2024, Vol. 30 ›› Issue (11): 1867-1872.DOI: 10.3760/cma.j.issn.1007-1245.2024.11.022

无抽搐电休克联合SSRI治疗对重度抑郁症患者认知功能的影响

谢凡¹ 巫宇丛² 温友禄³ 黄文鑫¹ 杨明明² 魏邵飞⁴ 柯畲林⁴ 屠宏光³

¹广州市番禺区第二人民医院麻醉科，广州　511430；²广东三九脑科医院麻醉科，广州　510510；³广东中能建电力医院心理科，广州　510760；⁴广东中能建电力医院麻醉科，广州　510760

收稿日期:2023-09-11 出版日期:2024-06-01 发布日期:2024-06-25
通讯作者: 谢凡，Email：gz_xiefan@hotmail.com
基金资助:
广东省医学科学技术研究基金（B2022120）

Effect of modified electric convulsive therapy combined with SSRIS on cognitive function in patients with severe depression

Xie Fan¹, Wu Yucong², Wen Youlu³, Huang Wenxin¹, Yang Mingming², Wei Shaofei⁴, Ke Shelin⁴, Tu Hongguang³

¹Department of Anesthesia, Second People's Hospital of Panyu District, Guangzhou 511430, China; ²Department of Anesthesia, Guangdong 999 Brain Hospital, Guangzhou 510510, China; ³Department of Psychology, Guangdong Zhongnengjian Dianli Hospital, Guangzhou 510760, China;⁴Department of Anesthesia, Guangdong Zhongnengjian Dianli Hospital, Guangzhou 510760, China

Received:2023-09-11 Online:2024-06-01 Published:2024-06-25
Contact: Xie Fan, Email: gz_xiefan@hotmail.com
Supported by:
Project Supported by Research Fund for Medical Science and Technology in Guangdong (B2022120)

摘要/Abstract

摘要：

目的　探讨无抽搐电休克（MECT）联合五羟色胺再摄取抑制剂（SSRI）治疗对重度抑郁症患者认知功能的影响。方法　采用前瞻性、单盲、随机对照的初步试验，选取2022年6月至2023年6月在广东中能建电力医院住院的重度抑郁症患者50例，按随机数字表法分为观察组（25例）和对照组（25例）。其中，观察组男14例，女11例，年龄（35.32±3.66）岁，病程（7.56±1.45）个月；对照组男10例，女15例，年龄（34.98±3.09）岁，病程（8.12±1.26）个月。观察组使用MECT（每周3次，疗程为4周）和SSRI类药物（舍曲林100～200 mg/d，疗程为2周）联合治疗，对照组仅使用和观察组相同的SSRI类药物治疗。比较两组患者治疗前和治疗后第2、4周抑郁情况（HAMD-24）、执行能力（WCST）、记忆功能（WAIS-RC）及决策能力（IGT）的差异，组间比较采用独立样本t检验、χ²检验。结果　在治疗后第2周、4周，观察组HAMD-24总分分别为（23.61±3.27）分、（18.43±5.22）分，均低于对照组［（29.41±3.13）分、（21.63±5.32）分］，两组比较差异均有统计学意义（均P<0.05）。在治疗后第4周，观察组WSCT中完成分类数为（6.13±2.01）分，高于对照组（5.21±1.72）分，但两组比较差异无统计学意义（P>0.05）。在治疗后第2周，观察组WAIS-RC总分（10.51±3.50）分、正序分（8.64±1.24）分、逆序分（3.16±1.21）分，均低于对照组的（13.67±4.13）分、（11.22±2.21）分、（4.20±1.15）分（均P<0.05）。在治疗后第2周，观察组总净得分（1.63±0.21）分，高于对照组的（1.27±0.56）分（P<0.05）；治疗后第4周，观察组总净得分（2.64±1.21）分，高于对照组的（1.67±0.74）分（P<0.05）。结论　MECT联合SSRI类药物治疗对重度抑郁症患者效果显著，能够有效改善其认知功能，效果优于单药治疗，MECT对患者工作与记忆功能存在短暂影响，但随着时间延长患者工作与记忆功能可恢复。

关键词:

重度抑郁症, 无抽搐电休克, 五羟色胺再摄取抑制剂, 认知功能

Abstract:

Objective　To investigate the effect of modified electric convulsive therapy (MECT) combined with serotonin reuptake inhibitors (SSRI) on cognitive function in patients with severe depression. Methods　A total of 50 patients with severe depression admitted to Guangdong Zhongnengjian Dianli Hospital from June 2022 to June 2023 were selected for the randomized controlled trial, and were divided into an experimental group and a control group by the random number table method, with 25 cases in each group. There were 14 males and 11 females in the experimental group; they were (35.32±3.66) years old; their disease course was (7.56±1.45) months. There were 10 males and 15 females in the control group; they were (34.98±3.09) years old; their disease course was (8.12±1.26) months. The experimental group took MECT 3 times a week for 4 weeks and SSRI sertraline 100-200 mg/d for 2 weeks, while the control group only took sertraline. The scores of Hamilton Depression Scale (HAMD-24), Wisconsin Card Sorting Test (WCST), Wechsler Adult Intelligence Scale (WAIS-RC), and Iowa Gambling Task (IGT) before the treatment and after 2 and 4 weeks' treatment were compared between the two groups by the independent-sample t test and χ² test. Results　The scores of HAMD-24 after 2 and 4 weeks' treatment in the observation group were lower than those in the control group [(23.61±3.27) vs. (29.41±3.13) and (18.43±5.22) vs. (21.63±5.32)], with statistical differences between the two groups (both P<0.05). After 4 weeks' treatment, the score of the number of completed classification in WSCT of the observation group was significantly higher than that of the control group [(6.13±2.01) vs. (5.21±1.72)], with no statistical difference between the two groups (P>0.05). The total score and the scores of positive and negative sequences of WAIS-RC after 2 weeks' treatment in the observation group were lower than those in the control group [(10.51±3.50) vs. (13.67±4.13), (8.64±1.24) vs. (11.22±2.21), and (3.16±1.21) vs. (4.20±1.15); all P<0.05]. The total net scores after 2 and 4 weeks' treatment in the observation group were higher than those in the control group [(1.63±0.21) vs. (1.27±0.56) and (2.64±1.21) vs. (1.67±0.74); both P<0.05]. Conclusion　MECT combined with SSRI for patients with severe depression is more effective than SSRI monotherapy, and can effectively improve their cognitive function, and has short-term effect on their working and memory function, but with the extension of time, their working and memory function will restore.

Key words:

Severe depression, Modified electric convulsive therapy, Serotonin reuptake inhibitors, Cognitive function

谢凡巫宇丛温友禄黄文鑫杨明明魏邵飞柯畲林屠宏光.

无抽搐电休克联合SSRI治疗对重度抑郁症患者认知功能的影响 [J]. 国际医药卫生导报, 2024, 30(11): 1867-1872.

Xie Fan, Wu Yucong, Wen Youlu, Huang Wenxin, Yang Mingming, Wei Shaofei, Ke Shelin, Tu Hongguang.

Effect of modified electric convulsive therapy combined with SSRIS on cognitive function in patients with severe depression [J]. International Medicine and Health Guidance News, 2024, 30(11): 1867-1872.

参考文献

[1] Li X, Meng H, Fu Y, et al. The Impact of whole brain global functional connectivity density following MECT in major depression: a follow-up study[J]. Front Psychiatry, 2019,10:7. DOI: 10.3389/fpsyt.2019.00007.
[2] Ahmadi N, Moss L, Hauser P, et al. Clinical outcome of maintenance electroconvulsive therapy in comorbid Posttraumatic Stress Disorder and major depressive disorder[J]. J Psychiatr Res, 2018,105:132-136. DOI: 10.1016/j.jpsychires.2018.08.023.
[3] Horowitz MA, Taylor D. Tapering of SSRI treatment to mitigate withdrawal symptoms[J]. Lancet Psychiatry, 2019,6(6):538-546. DOI: 10.1016/S2215-0366(19)30032-X.
[4] Bartels C, Wagner M, Wolfsgruber S, et al. Impact of SSRI therapy on risk of conversion from mild cognitive impairment to alzheimer's dementia in individuals with previous depression[J]. Am J Psychiatry, 2018,175(3):232-241. DOI: 10.1176/appi.ajp.2017.17040404.
[5] Gorka SM, Young CB, Klumpp H, et al. Emotion-based brain mechanisms and predictors for SSRI and CBT treatment of anxiety and depression: a randomized trial[J]. Neuropsychopharmacology, 2019,44(9):1639-1648. DOI: 10.1038/s41386-019-0407-7.
[6] Beyer JL, Johnson KG. Advances in pharmacotherapy of late-life depression[J]. Curr Psychiatry Rep, 2018,20(5):34. DOI: 10.1007/s11920-018-0899-6.
[7] Liao Y, Zhou G, Liang J, et al. Overall population generalities, sex Differences, and individual differences in sleep electroencephalography functional connectivity[J]. IEEE Access, 2019, 7: 160901-160915. DOI: 10.1109/ACCESS.2019.2950066
[8] Mahato S, Paul S. Classification of depression patients and normal subjects based on electroencephalogram (EEG) signal using alpha power and theta asymmetry[J]. J Med Syst, 2019,44(1):28. DOI: 10.1007/s10916-019-1486-z.
[9] Zhou G, Pan Y, Yang J, et al. Sleep Electroencephalographic response to respiratory events in patients with moderate sleep apnea-hypopnea syndrome[J]. Front Neurosci, 2020,14:310. DOI: 10.3389/fnins.2020.00310.
[10] Hein M, Lanquart JP, Loas G, et al. Alterations of neural network organisation during rapid eye movement sleep and slow-wave sleep in major depression: Implications for diagnosis, classification, and treatment[J]. Psychiatry Res Neuroimaging, 2019,291:71-78. DOI: 10.1016/j.pscychresns.2019.08.003.
[11] Cheng W, Rolls ET, Ruan H, et al. Functional connectivities in the brain that mediate the association between depressive problems and sleep quality[J]. JAMA Psychiatry, 2018,75(10):1052-1061. DOI: 10.1001/jamapsychiatry.2018.1941.
[12] 孙也婷,陈桃林,何度,等. 基于精神影像和人工智能的抑郁症客观生物学标志物研究进展[J]. 生物化学与生物物理进展,2019,46(9):879-899. DOI:10.16476/j.pibb.2019.0025.
[13] Riemann D, Krone LB, Wulff K, et al. Sleep, insomnia, and depression[J]. Neuropsychopharmacology, 2020,45(1):74-89. DOI: 10.1038/s41386-019-0411-y.
[14] 矫健萍,胡健波,黄满丽. 伏硫西汀对抑郁症疗效、认知功能和BDNF影响的研究进展[J]. 中国现代医生,2020,58(9):184-188.
[15] 张颖,李刚,王若梅,等. 单相抑郁患者缓解期认知功能损害观察[J]. 国际精神病学杂志,2019,46(2):246-248,255. DOI:10.13479/j.cnki.jip.2019.02.015
[16] Correia-Melo FS, Leal GC, Vieira F, et al. Efficacy and safety of adjunctive therapy using esketamine or racemic ketamine for adult treatment-resistant depression: a randomized, double-blind, non-inferiority study[J]. J Affect Disord, 2020,264:527-534. DOI: 10.1016/j.jad.2019.11.086.
[17] Zheng W, Cai DB, Xiang YQ, et al. Adjunctive intranasal esketamine for major depressive disorder: a systematic review of randomized double-blind controlled-placebo studies[J]. J Affect Disord, 2020,265:63-70. DOI: 10.1016/j.jad.2020.01.002.
[18] Zhou GL, Pan Y, Yang J, et al. Sleep electroencephalographic response to respiratory events in patients with moderate sleep apnea hypopnea syndrome[J]. Frontiers in Neuroscience,2020, 14:310. DOI: 10.3389/fnins.2020.00310.
[19] Yang J, Pan Y, Wang T, et al. Sleep-dependent directional interactions of the central nervous system-cardiorespiratory network[J]. IEEE Trans Biomed Eng, 2021,68(2):639-649. DOI: 10.1109/TBME. 2020.3009950.
[20] Liao YY, Zhou GL, Liang JX, et al. Overall population generalities, sex differences, and individual differences in sleep electroencephalography functional connectivity[J]. IEEE Access, 2019,7:160901-160915. DOI: 10.1109/ACCESS.2019.2950066
[21] 李昱,付艳梅. 改良电休克疗法联合选择性5-羟色胺再摄取抑制剂治疗中重度抑郁症患者的疗效观察[J]. 世界临床药物,2018,39(3):187-189,210. DOI:10.13683/j.wph. 2018.03.009.
[22] 宗哲,刘鑫,张四喜. 抗抑郁药物在综合性医院门诊中的应用情况及人群特点分析[J]. 中国医药,2019,14(1):112-116. DOI:10.3760/j.issn.1673-4777.2019.01.028.
[23] 沈渔邨.精神病学[M].５版.北京:人民卫生出版社,2015:245-246..
[24] 胡靖,张家秀. 精神分裂症认知测评及矫正对症状转归的影响[J]. 中国现代医学杂志,2019,29(6):100-104. DOI:10.3969/j.issn.1005-8982.2019.06.023.
[25] 龚耀先.中国修订韦氏成人智力量表(WAIS-RC)手册[M].长沙:湖南地图出版社, 1992:1-27.
[26] Kim YT, Sohn H, Kim S, et al. Disturbances of motivational balance in chronic schizophrenia during decision-making tasks[J]. Psychiatry Clin Neurosci, 2012,66(7):573-581. DOI: 10.1111/j.1440-1819.2012.02403.x.
[27] 杨洁,王刚. 新型5-羟色胺再摄取抑制剂的抗抑郁治疗:多受体效应与临床作用[J]. 中华精神科杂志,2018,51(2):145-148. DOI:10.3760/cma.j.issn.1006-7884. 2018.02.013.
[28] 高庆,李志雄,杨亚黎,等. SSRIs联合不同剂量坦度螺酮治疗伴有焦虑抑郁症的疗效和安全性[J]. 重庆医学,2018,47(32):4126-4129. DOI:10.3969/j.issn.1671-8348. 2018.32.011.
[29] 黄良峰,陈洋洋,赵炳功,等. 抑郁症的成因及其新药治疗研究进展[J]. 现代生物医学进展,2018,18(1):180-185. DOI:10.13241/j.cnki.pmb.2018.01.039.
[30] 谢莉,刘光亚,刘芳,等. 抗抑郁药联合无抽搐电休克对重度抑郁症患者认知功能及NSE的影响[J]. 精神医学杂志,2019,32(4):265-267. DOI:10.3969/j.issn.2095-9346. 2019.04.007.
[31] 赵景燕. 帕罗西汀联合唑吡坦治疗抑郁症失眠的临床疗效研究[J]. 国际医药卫生导报,2019,25(3):456-458. DOI:10.3760/cma.j.issn.1007-1245.2019.03.038.
[32] 蔡珊,陶筱琴,陈桂梅. 无抽搐电休克治疗对抑郁症病人认知功能的影响[J]. 护理研究,2017,31(23):2942-2944. DOI:10.3969/j.issn.1009-6493.2017.23.041.
[33] 徐洪,谷悦,王军,等. 选择性5-羟色胺再摄取抑制剂对重性抑郁症患者社会认知功能的影响[J]. 神经疾病与精神卫生,2018,18(10):722-726. DOI:10.3969/j.issn.1009-6574. 2018.10.009.
[34] 周朝雄,熊建文,付屹. 无抽搐电休克疗法对精神分裂症患者认知功能的影响[J]. 白求恩医学杂志,2015,13(4):391-392. DOI:10.16485/j.issn.2095-7858.2015.04.028.
[35] 谢琴,王高华,刘连忠,等. 无抽搐电休克治疗老年难治性抑郁症临床研究[J]. 精神医学杂志,2016,29(1):9-12. DOI:10.3969/j.issn.2095-9346.2016.01.003.

无抽搐电休克联合SSRI治疗对重度抑郁症患者认知功能的影响

Effect of modified electric convulsive therapy combined with SSRIS on cognitive function in patients with severe depression

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	王婧蔡春茜陈晓娜王雪薛米娜牛亚利. 中医导引功法组方治疗血管性轻度认知障碍的疗效研究 [J]. 国际医药卫生导报, 2024, 30(4): 651-656.
[2]	王灵芝杜圆圆刘艳. 尤瑞克林与丁苯酞治疗急性脑梗死患者的效果 [J]. 国际医药卫生导报, 2024, 30(3): 409-413.
[3]	项琳程院珍. 慢性病轨迹框架下目标管理对脑卒中术后恢复的影响 [J]. 国际医药卫生导报, 2023, 29(9): 1308-1313.
[4]	宋志永张晓华李泉王昭安任高燕. 瑞马唑仑联合阿芬太尼在老年患者无痛胃肠镜检查中的应用效果 [J]. 国际医药卫生导报, 2023, 29(24): 3625-3628.
[5]	翁瑜君陈志宁梁伟海余永森林国伟唐梁刘晓俊. 智三针疗法对PSCI大鼠学习和记忆能力的影响 [J]. 国际医药卫生导报, 2023, 29(23): 3417-3421.
[6]	曹伯宁陈丽萍侯怀晶徐紫清薛建军王春爱. 电针防治术后认知功能障碍的文献计量学及选穴分析 [J]. 国际医药卫生导报, 2023, 29(21): 3023-3029.
[7]	王晓妮陈宏盛王玉萍. 基于自我控制训练的GCBT在青少年抑郁障碍患者中的干预效果 [J]. 国际医药卫生导报, 2023, 29(21): 3070-3076.
[8]	徐君杜娟李敏刘星星. 脑循环治疗对老年脑梗死认知功能及日常生活活动能力的疗效研究 [J]. 国际医药卫生导报, 2023, 29(18): 2588-2592.
[9]	李荔丽冯趁霞冯桂真孟双楠李喜龙. 艾司氯胺酮联合不同剂量右美托咪定对肺癌手术患者的镇痛效果研究 [J]. 国际医药卫生导报, 2023, 29(13): 1845-1849.
[10]	温海茹张乐张琴. 右美托咪定复合小剂量舒芬太尼在老年无痛胃肠镜中的效果及对认知功能影响 [J]. 国际医药卫生导报, 2023, 29(10): 1396-1399.
[11]	周建国符大勇卢明聪孟云马先军. 定量脑电图在脑血管病方面的临床应用进展 [J]. 国际医药卫生导报, 2023, 29(1): 1-.
[12]	龚晨, 申潇竹, 包勤文, 赵晓斐. 维生素D水平与老年脑小血管病患者认知功能障碍的相关性研究[J]. 国际医药卫生导报, 2022, 28(8): 1081-1085.
[13]	蒋佳, 周静怡, 纪小静, 胡小静. 基于扎根理论的干预措施应用于老年糖尿病患者中的效果观察[J]. 国际医药卫生导报, 2022, 28(5): 641-645.
[14]	李艺. 术前高压氧处理对冠状动脉搭桥术患者术后的影响分析[J]. 国际医药卫生导报, 2022, 28(3): 425-428.
[15]	王冰艳刘爱芬孙凤仙. 依托咪酯通过调控MAPK/ERK信号通路对阿尔茨海默病小鼠认知功能和氧化应激的影响[J]. 国际医药卫生导报, 2022, 28(22): 3118-3123.